Opioid victims are not getting a "fair shake" in potential $7.4 billion settlement, a claimant in the Purdue Pharmacy ...

Here's why people alleging Purdue Pharma's opioids harmed them may not see much of the proposed $7.4 billion settlement in a bankruptcy case.

"71 out of 72 Wisconsin counties filed lawsuits against Purdue Pharma. Brad Schimel refused to join them," the ad states. That refers to litigation launched around 2017 in Wisconsin and nationwide ...

In an opinion issued on Jan. 24, 2025, on a motion for a stay pending appeal of the court’s decision that a Bankruptcy Code ...

Purdue Pharma and owners to pay $7.4 billion in settlement of lawsuits over the toll of OxyContin Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay ...

A judge in the US has approved the sale of Purdue Pharma’s consumer health business ... drugmaker’s proposed $10 billion settlement of claims that it helped to fuel the opioid crisis in ...

Earlier this year, Oklahoma resolved a claim against Purdue Pharma for $270 million, which went toward funding addiction research and treatment as well as legal fees. Close to 400,000 Americans ...

Purdue Pharma, manufacturer of the highly addictive ... The crux of the issue is simple. Claims were made that oxycontin was less addictive than other similar pain medications.

Judge Littlefield is deciding whether to permit several child sexual abuse lawsuits against the Roman Catholic Diocese of Albany to go to trial as a method to kick start settlement discussions.